OmniSpirant Therapeutics
Pre-clinicalOmniSpirant develop inhaled regenerative gene therapy for cystic fibrosis and other lung diseases such as COPD based on the proprietary engineered stem cell exosome platform technology
Founded
2020
Focus
BiologicsDrug Delivery
About
OmniSpirant develop inhaled regenerative gene therapy for cystic fibrosis and other lung diseases such as COPD based on the proprietary engineered stem cell exosome platform technology
Funding History
1Total raised: $4M
Seed$4MKernel CapitalNov 15, 2021
Company Info
TypePrivate
Founded2020
LocationDublin, Ireland
StagePre-clinical
Contact
SIMILAR COMPANIES
Remedy Biologics
Pre-clinical · Dublin
Aerogen
Pre-clinical · Galway
Bio Pharma Technical Consulting
Pre-clinical · Dublin
Astoriom
Pre-clinical · Dublin
Atlantia Clinical Trials
Pre-clinical · Cork
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile